Transfection of anti-BCKDK siRNA into non-small cell lung cancer cells, including A549, HCC827, and H1299, reduced the expression of BCKDK, decreased BCKDE1α phosphorylation, and inhibited the proliferation of tumor cells in these cancers. Here, BCKDK is linked to non-small cell lung carcinoma.